Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/22/2012US20120071501 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
03/22/2012US20120071500 Macrocyclic lactone compounds and methods for their use
03/22/2012US20120071499 Substituted Spiro[3H-Indole-3,6'(5'H)-[1H]Pyrrolo[1,2c]Imidazole-1',2(1H,2'H)-diones
03/22/2012US20120071498 Therapeutic composition to treat lesions caused by herpes simplex virus
03/22/2012US20120071497 Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
03/22/2012US20120071496 Aminopyrimidinamides As Pest Control Agents
03/22/2012US20120071495 Treatment for Neurological and Mental Disorders
03/22/2012US20120071494 Pyrazolopyridine kinase inhibitors
03/22/2012US20120071493 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
03/22/2012US20120071492 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
03/22/2012US20120071491 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
03/22/2012US20120071490 P70 s6 kinase inhibitors
03/22/2012US20120071489 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
03/22/2012US20120071488 Melting tablet containing a sildenafil salt
03/22/2012US20120071487 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071485 Therapeutic Compositions And Methods
03/22/2012US20120071484 Topical Parasiticide Composition
03/22/2012US20120071483 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
03/22/2012US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/22/2012US20120071481 Isoxazole-5-carboxamide derivatives
03/22/2012US20120071480 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
03/22/2012US20120071479 Pyrazine derivatives as enac blockers
03/22/2012US20120071478 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071476 Morpholinopurine derivatives
03/22/2012US20120071475 Urea derivatives having pi3k-inhibiting activity
03/22/2012US20120071474 Inhibitors of pi3 kinase
03/22/2012US20120071473 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
03/22/2012US20120071472 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
03/22/2012US20120071471 Novel benzoxazinone derivatives useful for the treatment of cns disorders
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071469 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
03/22/2012US20120071468 Methods of treating mild cognitive impairment (mci) and related disorders
03/22/2012US20120071467 Amide derivative
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120071465 Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
03/22/2012US20120071464 Method of treatment of obsessive compulsive disorder with ondansetron
03/22/2012US20120071463 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/22/2012US20120071462 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
03/22/2012US20120071461 Substituted Benzamide Compounds
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/22/2012US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/22/2012US20120071458 Methods for treating obesity
03/22/2012US20120071457 Metallo-beta-lactamase inhibitors
03/22/2012US20120071456 Composition
03/22/2012US20120071455 6-substituted demethyl-estradiol derivatives as selective er-beta agonists
03/22/2012US20120071454 Steroid Compounds and Treatment Methods
03/22/2012US20120071453 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
03/22/2012US20120071452 Combinations comprising antimuscarinic agents and corticosteriods
03/22/2012US20120071451 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071449 Pharmaceutical composition for inhalation
03/22/2012US20120071448 S1P3 Receptor Inhibitors for Treating Conditions of the Eye
03/22/2012US20120071447 Antiviral Drugs for Treatment of Arenavirus Infection
03/22/2012US20120071446 Dosage regimen of an s1p receptor agonist
03/22/2012US20120071445 Combination Therapy for the Treatment of Multiple Myeloma
03/22/2012US20120071444 Method and composition for the control of ectoparasites
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071442 Lipid conjugates in the treatment of chronic rhinosinusitis
03/22/2012US20120071441 6'-sialyllactose salts and process for their synthesis and for the synthesis of other alpha-sialyloligosaccharides
03/22/2012US20120071440 Pharmaceutical Composition For Enhancing Adiponectin Production And Food Useful Therefor
03/22/2012US20120071439 Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
03/22/2012US20120071437 Tunable crosslinked polysaccharide compositions
03/22/2012US20120071436 Method, composition and kit for antigenic binding of norwalk-like viruses
03/22/2012US20120071435 Pharmaceutical combinations comprising for the treatment of specific cancers
03/22/2012US20120071434 Substituted nucleotide analogs
03/22/2012US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives
03/22/2012US20120071432 Central administration of stable formulations of therapeutic agents for cns conditions
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
03/22/2012US20120071430 Synthetic analogs of bacterial quorum sensors
03/22/2012US20120071429 Novel antibacterial agents
03/22/2012US20120071427 Novel antidiabetic furostanolic saponin rich (fsr) fraction from fenugreek seeds
03/22/2012US20120071426 Methods and compositions for treating lung cancer
03/22/2012US20120071425 Uses of mannose-6-phosphate
03/22/2012US20120071424 Pharmaceutical composition used in prophylaxis or treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient
03/22/2012US20120071423 Heterotricyclic AMPA Receptor Antagonists for Treatment of Epilepsy, Pain, and Other Neurological Disorders and Diseases
03/22/2012US20120071418 Inhibitors of Human EZH2 and Methods of Use Thereof
03/22/2012US20120071417 Methods of inhibiting cancer cell growth with hdac inhibitors and methods of screening for hdac10 inhibitors
03/22/2012US20120071414 Method for producing and using active principles of limestone
03/22/2012US20120071406 Modified vegf-a with improved angiogenic properties
03/22/2012US20120071403 Methods for Treating Type 2 Diabetes in Patients Resistant to Previous Treatment with other Anti-Diabetic Drugs Employing an SGLT2 Inhibitor and Compositions Thereof
03/22/2012US20120070520 Composition containing a bean extract for improving blood circulation and increasing vascular health
03/22/2012US20120070519 Method for extraction of fractions containing pharmacologically active ingredients with less cytotoxicity from one or more plants
03/22/2012US20120070518 Methods and compositions for treating psoriasis
03/22/2012US20120070513 Method and Composition for Treating Diabetic Ketoacidosis
03/22/2012US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives
03/22/2012US20120070511 Mitochondrial inhibitors and uses thereof
03/22/2012US20120070507 Compositions and Methods for the Treatment of Soft Tissue Injury
03/22/2012US20120070505 Functional amphipilic molecule or macromolecule formulations with multiple compartments
03/22/2012US20120070503 Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation
03/22/2012US20120070501 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
03/22/2012US20120070499 Delayed-release glucocorticoid treatment of rheumatoid disease
03/22/2012US20120070498 Submicron Particles of Antineoplastic Agents
03/22/2012US20120070497 Use of boswellic acids for the prophylaxis and/or treatment of damage to and/or inflammation of the islets of langerhans
03/22/2012US20120070496 Antidepressant dosage form
03/22/2012US20120070495 Oral formulations and lipophilic salts of methylnaltrexone
03/22/2012US20120070494 Treatment for Attention-Deficit Hyperactivity Disorder
03/22/2012US20120070492 Rhein or diacerein compositions
03/22/2012US20120070489 Combination therapy for treatment of fiv infection
1 ... 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 ... 7860